227 related articles for article (PubMed ID: 26362310)
1. Chemotherapy induces Notch1-dependent MRP1 up-regulation, inhibition of which sensitizes breast cancer cells to chemotherapy.
Kim B; Stephen SL; Hanby AM; Horgan K; Perry SL; Richardson J; Roundhill EA; Valleley EM; Verghese ET; Williams BJ; Thorne JL; Hughes TA
BMC Cancer; 2015 Sep; 15():634. PubMed ID: 26362310
[TBL] [Abstract][Full Text] [Related]
2. Allyl isothiocyanate may reverse the expression of MRP1 in COPD rats via the Notch1 signaling pathway.
Wu J; Wang X; Yao Z; Wu Q; Fang W; Li Z; Wang D
Arch Pharm Res; 2019 Nov; 42(11):1000-1011. PubMed ID: 31571144
[TBL] [Abstract][Full Text] [Related]
3. miR-145 sensitizes breast cancer to doxorubicin by targeting multidrug resistance-associated protein-1.
Gao M; Miao L; Liu M; Li C; Yu C; Yan H; Yin Y; Wang Y; Qi X; Ren J
Oncotarget; 2016 Sep; 7(37):59714-59726. PubMed ID: 27487127
[TBL] [Abstract][Full Text] [Related]
4. NFκBP65 transcription factor modulates resistance to doxorubicin through ABC transporters in breast cancer.
Velaei K; Samadi N; Soltani S; Barazvan B; Soleimani Rad J
Breast Cancer; 2017 Jul; 24(4):552-561. PubMed ID: 27878697
[TBL] [Abstract][Full Text] [Related]
5. Doxorubicin induces expression of multidrug resistance-associated protein 1 in human small cell lung cancer cell lines by the c-jun N-terminal kinase pathway.
Shinoda C; Maruyama M; Fujishita T; Dohkan J; Oda H; Shinoda K; Yamada T; Miyabayashi K; Hayashi R; Kawagishi Y; Fujita T; Matsui S; Sugiyama E; Muraguchi A; Kobayashi M
Int J Cancer; 2005 Oct; 117(1):21-31. PubMed ID: 15880572
[TBL] [Abstract][Full Text] [Related]
6. Notch1 is associated with the multidrug resistance of hypoxic osteosarcoma by regulating MRP1 gene expression.
Li C; Guo D; Tang B; Zhang Y; Zhang K; Nie L
Neoplasma; 2016; 63(5):734-42. PubMed ID: 27468877
[TBL] [Abstract][Full Text] [Related]
7. ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a gamma-secretase inhibitor.
Osipo C; Patel P; Rizzo P; Clementz AG; Hao L; Golde TE; Miele L
Oncogene; 2008 Aug; 27(37):5019-32. PubMed ID: 18469855
[TBL] [Abstract][Full Text] [Related]
8. Allyl isothiocyanate upregulates MRP1 expression through Notch1 signaling in human bronchial epithelial cells.
Li NN; Guo Y; Jiang CJ; Zhou YY; Li CH; Li ZG; Wang DL
Can J Physiol Pharmacol; 2020 May; 98(5):324-331. PubMed ID: 31747319
[TBL] [Abstract][Full Text] [Related]
9. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
10. Resveratrol enhances chemosensitivity of doxorubicin in multidrug-resistant human breast cancer cells via increased cellular influx of doxorubicin.
Kim TH; Shin YJ; Won AJ; Lee BM; Choi WS; Jung JH; Chung HY; Kim HS
Biochim Biophys Acta; 2014 Jan; 1840(1):615-25. PubMed ID: 24161697
[TBL] [Abstract][Full Text] [Related]
11. Multidrug resistance associated genes MRP1, MRP2 and MRP3 in primary and anthracycline exposed breast cancer.
Faneyte IF; Kristel PM; van de Vijver MJ
Anticancer Res; 2004; 24(5A):2931-9. PubMed ID: 15517899
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy induces expression levels of breast cancer resistance protein that predict disease-free survival in breast cancer.
Kim B; Fatayer H; Hanby AM; Horgan K; Perry SL; Valleley EM; Verghese ET; Williams BJ; Thorne JL; Hughes TA
PLoS One; 2013; 8(5):e62766. PubMed ID: 23658771
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of Notch1 increases paclitaxel sensitivity to human breast cancer.
Zhao L; Ma Y; Gu F; Fu L
Chin Med J (Engl); 2014; 127(3):442-7. PubMed ID: 24451948
[TBL] [Abstract][Full Text] [Related]
14. Allyl isothiocyanate treatment alleviates chronic obstructive pulmonary disease through the Nrf2-Notch1 signaling and upregulation of MRP1.
Zhou Y; Xu X; Wu J; Xu L; Zhang M; Li Z; Wang D
Life Sci; 2020 Feb; 243():117291. PubMed ID: 31927049
[TBL] [Abstract][Full Text] [Related]
15. Notch1 signaling regulates the epithelial-mesenchymal transition and invasion of breast cancer in a Slug-dependent manner.
Shao S; Zhao X; Zhang X; Luo M; Zuo X; Huang S; Wang Y; Gu S; Zhao X
Mol Cancer; 2015 Feb; 14(1):28. PubMed ID: 25645291
[TBL] [Abstract][Full Text] [Related]
16. Function of Integrin-Linked Kinase in Modulating the Stemness of IL-6-Abundant Breast Cancer Cells by Regulating γ-Secretase-Mediated Notch1 Activation in Caveolae.
Hsu EC; Kulp SK; Huang HL; Tu HJ; Salunke SB; Sullivan NJ; Sun D; Wicha MS; Shapiro CL; Chen CS
Neoplasia; 2015 Jun; 17(6):497-508. PubMed ID: 26152358
[TBL] [Abstract][Full Text] [Related]
17. Expression of MRP1, LRP and Pgp in breast carcinoma patients treated with preoperative chemotherapy.
Rudas M; Filipits M; Taucher S; Stranzl T; Steger GG; Jakesz R; Pirker R; Pohl G
Breast Cancer Res Treat; 2003 Sep; 81(2):149-57. PubMed ID: 14572157
[TBL] [Abstract][Full Text] [Related]
18. MRP1 but not MDR1 is associated with response to neoadjuvant chemotherapy in breast cancer patients.
Taheri M; Mahjoubi F
Dis Markers; 2013; 34(6):387-93. PubMed ID: 23481629
[TBL] [Abstract][Full Text] [Related]
19. 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity.
Rocha Gda G; Oliveira RR; Kaplan MA; Gattass CR
Eur J Pharmacol; 2014 Oct; 741():140-9. PubMed ID: 25111243
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment with the γ-secretase inhibitor DAPT sensitizes drug-resistant ovarian cancer cells to cisplatin by downregulation of Notch signaling.
Wang M; Ma X; Wang J; Wang L; Wang Y
Int J Oncol; 2014 Apr; 44(4):1401-9. PubMed ID: 24535252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
